comparing afami-cel with existing treatments in synovial sarcoma
Published 1 month ago • 92 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
0:50
spearhead-1: afamitresgene autoleucel in advanced synovial sarcoma
-
2:48
afamitresgene autoleucel (formerly adp-a2m4) in patients with advanced synovial sarcoma or myxoi...
-
1:58
the convergence of targeted therapies and immuno-oncology in sarcoma
-
1:00
new approaches for sarcoma
-
28:05
advances in therapy for sarcomas & gist
-
2:00:38
adaptimmune's symposium at ctos 2021– “spotlight on synovial sarcoma; where are we now? where next?”
-
2:36
the role of biomarkers in soft tissue sarcoma treatment and research
-
1:13
apromiss: anlotinib versus dacarbazine in advanced synovial sarcoma.
-
3:22
dr. sanjay bagaria: sarcoma - mayo clinic
-
2:39
apromiss: catequentinib in synovial sarcoma
-
8:17
targeted therapy advancements in sarcoma subtypes
-
1:09
know what your doctors know: soft tissue sarcoma q&a – post op pain
-
0:57
spearhead-1: afamitresgene autoleucel in advanced synovial and myxoid liposarcoma
-
1:44
efficacy and biomarker results for pembrolizumab in soft tissue and bone sarcomas
-
2:07
researchers working on making sarcoma vaccine more effective
-
7:04
collaboration of experts in soft tissue sarcoma
-
1:09
spearhead-1: adp-a2m4 in synovial sarcoma and mrcls
-
1:04
dr. philip on treatment challenges for patients with soft tissue sarcoma